Search Results for "risperdal"
- Supreme Court Lets J&J Risperdal Verdict Stand
The Supreme Court has spoken: A jury’s $70 million award to a man who developed gynecomastia while taking Risperdal as a child will stand. Johnson & Johnson took the case to the highest court in the land after losing the initial case and an appeal.
The case was brought by Adam Yount. Yount was...
- Multi-billion Dollar Risperdal Verdict Reduced to Less than $7 Million
After having his $1.75 million compensatory Risperdal verdict reduced to just $680,000, plaintiff Nicholas Murray thought that was the end of his legal battle against the company whose misconduct, he claimed, had caused him to form female breast tissue. That was when a Pennsylvania Superior Court ju...
- Johnson & Johnson Loses $70 Million Risperdal Appeal
A Tennessee man’s $70 million Risperdal award will stand, and the case could be eligible for punitive damages as well. This was the verdict handed down by a Pennsylvania appeals court after Johnson & Johnson appealed the initial jury award and attempted to have the verdict reversed.
The loss o...
- J&J Facing $8 Billion Jury Award in Risperdal Decision
When Nicholas Murray was awarded $1.75 million in compensatory damages over claims that Johnson & Johnson’s anti-psychotic medication Risperdal caused him to develop breast tissue, he had every reason to believe that his ordeal had finally begun to come to an end. Having been diagnosed with au...
- Judge Shocks Both Sides with Move to Dismiss Risperdal Case
Most of the time, a judge’s actions in a case are somewhat expected by at least one side. A plaintiff or defendant might argue for a particular action and the outcome is based on either the success or failure of that argument. However, every so often a judge does something that catches both sides ...
- J&J to Pay $7.8 Million in Arkansas Risperdal Lawsuit
Pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a seven-and-a-half-year-old Risperdal lawsuit, the Arkansas Democrat-Gazette reports. The state of Arkansas filed the lawsuit in 2007, alleging that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, unl...
- Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits
After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These dru...